research Reply to: Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
Search
for
Sort by
Research
90-120 / 1000+ results 
research Acutely Ill Patients in Internal Medicine Departments Want Treatment for Undiagnosed, Symptomatic Skin Conditions
Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.
research Self-Reported Hair Loss Following COVID-19: An Observational Study
Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.
research Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019
Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.
research Androgenetic Alopecia and COVID-19: Is There a Clinical Connection?
Androgenetic alopecia severity does not affect COVID-19 severity.
research A Case of Eruptive Lichen Spinulosus After Toxic Epidermal Necrolysis
A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.
research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations
COVID-19 infection may trigger alopecia areata in some patients.
research Plica Neuropathica: Novel Presentation of a Rare Disease
A girl with no hair neglect developed plica neuropathica in the hospital, lost all her hair, but it grew back.
research The Effect of COVID-19 on Development of Hair and Nail Disorders: A Turkish Multicenter, Controlled Study
COVID-19 can cause hair and nail disorders after infection.
research Kawasaki Disease and Alopecia Areata: Coincidence or True Association?
The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.
research The Management of EGFR Inhibitor Adverse Events: A Case Series and Treatment Paradigm
Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.
research Male Balding Is a Major Risk Factor for Severe COVID-19
Men with severe balding have a higher risk of getting very sick from COVID-19.
research The Polish Version of Skindex-29: Psychometric Properties of an Instrument to Measure Quality of Life in Dermatology
The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.
research Androgenetic Alopecia in COVID-19: Compared to What?
Hair loss link to severe COVID-19 unclear.
research Incidence of Adverse Cutaneous Drug Reactions in a Mexican Sample: An Exploratory Study on Their Association to Tumor Necrosis Factor Alpha TNF2 Allele
Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.
research Dermatology for the Elderly: An Indian Perspective
The paper concludes that elderly in India face unique skin challenges and need better dermatological care and awareness.
research Letters to Dermatology
Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.
research Comment on 'Androgens and Women: COVID-19 Outcomes in Women with Acne Vulgaris, Polycystic Ovarian Syndrome, and Hirsutism'
Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.
research Ingestion of Topical Steroid Triggering Pustular Psoriasis?
Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.
research Severe COVID-19 Infection Predisposes Patients to Greater Burden of Hair Loss
People who had severe COVID-19 are more likely to experience hair loss.
research Behavioral Dermatology
Behavioral dermatology treats skin problems by considering both emotional and physical factors.
research Tacrolimus in Dermatology
Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.
research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
research Commentary: Unroofing for Hidradenitis Suppurativa, Why and How
Unroofing is an effective, less invasive, and cost-effective surgery for hidradenitis suppurativa with low recurrence and improved patient quality of life.
research Drug Eruptions in Dermatology
Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.
research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
research Male Balding as a Major Risk Factor for Severe COVID-19: A Possible Role for Targeting Androgens and Transmembrane Protease Serine 2 to Protect Vulnerable Individuals
Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.
research Tacrolimus in Dermatology
Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.
research Pediatric Inpatients Requesting Dermatology Consultation in a Tertiary Care Hospital: Retrospective Analysis of 614 Patients
Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.
research Reply to Comment on: The Gabrin Sign
Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.